# Compass Therapeutics, Inc.: Form 8-K, filed Nov 9, 2023

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2023-11-09
- Accepted by EDGAR: Nov 9, 2023, 07:30 ET
- Period: 2023-11-09
- Accession: 0001171843-23-006911
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000117184323006911/f8k_110823.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000117184323006911/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000117184323006911/f8k_110823.htm

Filed Nov 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-006911. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.